Sentences with phrase «president of vaccine research»
People have attempted to make vaccines for group B N. meningitidis over the years, but it has been literally impossible, according to Rino Rappuoli, Vice President of Vaccine Research for the Chiron Corporation, and an author on both Science papers.
http://www.genomenewsnetwork.org/
«When viruses are unavailable for work in the lab, that is really a downside,» says Larry Smith, vice president of vaccine research at Vical Inc. in San Diego.
Not exact matches
The vaccine could even be described as «holistic,» according to Fred Ramsdell, vice president of research at the nonprofit Parker Institute.
Dr. Larry Corey, Principal Investigator, HIV Vaccine Trials Network; Past President and Director, Fred Hutchinson Cancer Research Center Dr. Diane Havlir, Professor of Medicine, University of California, San Francisco Moderator: Siobhan O'Connor, Time Magazine
«Understanding the host response will be a critical area in vaccine research,» says George Kemble, vice president of research and development for MedImmune Vaccines, recently purchased by AstraZeneca.
One of the Lyon - based investors is vaccine manufacturer Sanofi Pasteur, whose president, Jacques Berger, sees many benefits to the changes: «There's no rivalry between those who want to work in state - funded research and those who want to work in the private sector,» he says.
Ingo Potrykus at the Swiss Federal Institute of Technology is engineering a novel strain of rice fortified with extra iron and vitamin A. Charles Arntzen, president of the Boyce Thompson Institute for Plant Research at Cornell University, is working on perhaps the most ambitious genetically engineered food of all: an edible vaccine.
«It's not something that will be a panacea for all [cocaine] addicts,» says John Shields, senior vice president of research at Cantab Pharmaceuticals, a British company that recently bought ImmuLogic's vaccine program.
«This research team's dedication and previous research on dengue and other arboviruses enabled them to quickly develop this model for Zika virus, an important first step to enable testing of candidate vaccine and therapeutics,» said Stephen Higgs, PhD, the president of the American Society of Tropical Medicine and Hygiene.
President Barack Obama gave a talk at the NIH Clinical Center and then toured the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center.
«This is an important demonstration of the possibilities opened up for immunotherapy by DMAb technology to direct in vivo production of antibodies of major relevance to human cancer,» said David B. Weiner, Ph.D., executive vice president of The Wistar Institute, director of The Wistar Institute Vaccine & Immunotherapy Center, W.W. Smith Charitable Trust Professor in Cancer Research, and senior author of the study.
«We have learned in that period of time how formidable an adversary HIV is,» says immunologist Wayne Koff, senior vice president for research and development at the International AIDS Vaccine Initiative (IAVI).
Says Parker Institute Vice President for Research Fred Ramsdell: «At the end, we'll have a good idea of how to correctly pick neoantigens for a vaccine.»
Recently, industry leaders have expressed a desire to help, and in January, President Clinton announced his Millennium Vaccine Initiative, in which he proposed a series of measures to stimulate vaccine reVaccine Initiative, in which he proposed a series of measures to stimulate vaccine revaccine research.
«We have dozens of studies examining autism and vaccines, and they don't show a link,» says Alison Singer, president of the Autism Science Foundation, a nonprofit that supports autism research.
David B. Weiner, Ph.D., executive vice president, director of the Vaccine & Immunotherapy Center, and the W.W. Smith Endowed Chair in Cancer Research at The Wistar Institute, and peers received the 2018 Top Ten Clinical Research Achievement Award last night at the National Press Club in Washington, D.C.
In 2005, Dan co-founded and served as President and CEO of Inviragen Inc., which he transformed from a virtual start - up to a global clinical stage company with sites in Colorado, Wisconsin and Singapore and translated two vaccines from the research bench to human clinical trials, including one for dengue fever.
Weiner joined The Wistar Institute as the Executive Vice President, Director of the Vaccine & Immunotherapy Center, and W.W. Smith Charitable Trust Professor in Cancer Research in 2016.
At the Bangkok AIDS conference held in July of this year, Seth Berkley, IAVI's president, argued that «only a vaccine can end the epidemic,» that «a vaccine is achievable,» and that spending on vaccine research must double to $ 1.3 billion annually in order to find it.
«As I begin my service as ISV President, it is important to keep in mind that our overarching goals and focus remain the same: serve all of our members and continue to build the society and «lift all boats» in vaccine research around the globe,» Weiner said.
The Wistar Institute was awarded a $ 1,494,972 grant by the Bill & Melinda Gates Foundation to advance a DNA - based vaccine candidate for protection against malarial infection utilizing a synthetic DNA platform created in the lab of David B. Weiner, Ph.D., executive vice president, director of the Vaccine & Immunotherapy Center at The Wistar Institute and the W.W. Smith Charitable Trust Professor in Cancer Revaccine candidate for protection against malarial infection utilizing a synthetic DNA platform created in the lab of David B. Weiner, Ph.D., executive vice president, director of the Vaccine & Immunotherapy Center at The Wistar Institute and the W.W. Smith Charitable Trust Professor in Cancer ReVaccine & Immunotherapy Center at The Wistar Institute and the W.W. Smith Charitable Trust Professor in Cancer Research.
Between a research - gutting proposed budget, regulation - slashing executive orders, the appointment of climate change skeptics to head the Environmental Protection Agency and Department of Energy, and bogus claims about vaccines, infectious diseases, and global warming, it's no secret that President Donald Trump has demonstrated indifference to empirical fact and hostility to the scientific community.